FR2282898A1 - Steroides de la serie de l'androstane, leur preparation et leurs applications - Google Patents

Steroides de la serie de l'androstane, leur preparation et leurs applications

Info

Publication number
FR2282898A1
FR2282898A1 FR7526649A FR7526649A FR2282898A1 FR 2282898 A1 FR2282898 A1 FR 2282898A1 FR 7526649 A FR7526649 A FR 7526649A FR 7526649 A FR7526649 A FR 7526649A FR 2282898 A1 FR2282898 A1 FR 2282898A1
Authority
FR
France
Prior art keywords
applications
preparation
androstane series
steroids
series steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7526649A
Other languages
English (en)
French (fr)
Other versions
FR2282898B1 (enEXAMPLES
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Glaxo Laboratories Ltd
Original Assignee
Laboratoires Glaxo SA
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA, Glaxo Laboratories Ltd filed Critical Laboratoires Glaxo SA
Publication of FR2282898A1 publication Critical patent/FR2282898A1/fr
Application granted granted Critical
Publication of FR2282898B1 publication Critical patent/FR2282898B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7526649A 1974-08-30 1975-08-29 Steroides de la serie de l'androstane, leur preparation et leurs applications Granted FR2282898A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38089/74A GB1517278A (en) 1974-08-30 1974-08-30 Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates

Publications (2)

Publication Number Publication Date
FR2282898A1 true FR2282898A1 (fr) 1976-03-26
FR2282898B1 FR2282898B1 (enEXAMPLES) 1978-11-10

Family

ID=10401103

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7526649A Granted FR2282898A1 (fr) 1974-08-30 1975-08-29 Steroides de la serie de l'androstane, leur preparation et leurs applications

Country Status (12)

Country Link
US (1) US3981894A (enEXAMPLES)
JP (1) JPS5148648A (enEXAMPLES)
BE (1) BE832888A (enEXAMPLES)
CH (1) CH612687A5 (enEXAMPLES)
DE (1) DE2538627A1 (enEXAMPLES)
DK (1) DK136075B (enEXAMPLES)
FR (1) FR2282898A1 (enEXAMPLES)
GB (1) GB1517278A (enEXAMPLES)
IE (1) IE41662B1 (enEXAMPLES)
NL (1) NL7510225A (enEXAMPLES)
SE (1) SE411904B (enEXAMPLES)
ZA (1) ZA755554B (enEXAMPLES)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3002746A1 (de) * 1980-01-23 1981-07-30 Schering Ag Berlin Und Bergkamen, 1000 Berlin 1-hydroxysteroide, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
CA2417825C (en) * 2000-08-05 2008-07-22 Glaxo Group Limited 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
MY137522A (en) 2001-04-30 2009-02-27 Glaxo Group Ltd Novel anti-inflammatory androstane derivatives.
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828080A (en) * 1972-01-20 1974-08-06 Glaxo Lab Ltd Androstane-17beta-carboxylic acids and processes for the preparation thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
DK389375A (enEXAMPLES) 1976-03-01
AU8440375A (en) 1977-03-03
JPS5148648A (enEXAMPLES) 1976-04-26
SE411904B (sv) 1980-02-11
DK136075C (enEXAMPLES) 1978-01-09
ZA755554B (en) 1976-08-25
FR2282898B1 (enEXAMPLES) 1978-11-10
SE7509650L (sv) 1976-03-01
DE2538627A1 (de) 1976-03-11
BE832888A (fr) 1976-03-01
IE41662L (en) 1976-02-29
IE41662B1 (en) 1980-02-27
DK136075B (da) 1977-08-08
CH612687A5 (enEXAMPLES) 1979-08-15
US3981894A (en) 1976-09-21
GB1517278A (en) 1978-07-12
NL7510225A (nl) 1976-03-02

Similar Documents

Publication Publication Date Title
FR2282898A1 (fr) Steroides de la serie de l'androstane, leur preparation et leurs applications
FR2283679A1 (fr) 4-arylpiperidines 1,3,4-trisubstituees et leur preparation
BE826396A (fr) Melanges de copolyethers - esters, leur preparation et leurs applications
BE832311A (fr) Cyclopropylamides de peptides, leur preparation et leurs applications
BE841537A (fr) Melanges d'aminoalcanols, leur preparation et leurs utilisations
FR2282899A1 (fr) Steroides de la serie de l'androstane, leur preparation et leurs applications
BE833586A (fr) Aminobenzazocines et leur preparation
FR2282881A1 (fr) 2-carbalcoxyamino-5(6)-phenylsulfonyloxy-benzimidazoles, leur preparation et leurs applications
BE841536A (fr) Melanges d'aminoalcanols, leur preparation et leurs utilisations
BE825982A (fr) Triazoloquinazolines et leur preparation
FR2279823A1 (fr) Pigments bus-azoiques, leur preparation et leurs applications
FR2283689A1 (fr) Nouvelles cephamycines, leur preparation et leur application
NL7411968A (nl) Moeilijk ontvlambare en zelfdovende vormmassa's.
FR2275198A1 (fr) O-acyl-acrylaldoximes substituees, leur preparation et leurs applications
BE828447A (fr) Nouveaux steroides substitues en position 11 de la serie de l'oestrane
BE818751A (fr) Ethers 2,2,2-trifluoro-1-chloroethyliques, leur preparation et leurs applications
BE830239A (fr) Compositions de steroides stabilisees et leur preparation
BE776787A (fr) Nouveaux steroides de la serie du pregnane, leurs procedes de preparation et leurs applications
FR2281762A1 (fr) 3,4-dihydro-2h-isoquinoleine-1-thiones substituees, leur preparation et leurs applications
FR2293425A1 (fr) Nouveaux perfluoralcane-sulfamides, leur preparation et leurs applications
BE832274A (fr) Oxazolidinones, leur preparation et leurs applications
BE829153A (fr) 5-phenyl-thiazolidine-4-ones et leur preparation
BE835537A (fr) Colorants anthraquinoniques, leur ontention et leurs applications
BE824811A (fr) Diamino-guanidines substitues, leur preparation et leurs applications
FR2293937A1 (fr) Nouveaux steroides, leur procede de preparation et leurs applications

Legal Events

Date Code Title Description
ST Notification of lapse